Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung Cancer

Clinical trial NCT06065813 · UNKNOWN

Trial details

NCT number: NCT06065813
Sponsor: Northern Jiangsu People's Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Neoadjuvant Therapy Radiotherapy Immunotherapy

Start date: 2022-08-08
Primary completion: 2026-05-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.